Mei Lan Tan Selected Research

Mei Lan Tan Research Topics

4	Breast Neoplasms (Breast Cancer) 06/2016 - 01/2009
3	Neoplasms (Cancer) 03/2021 - 06/2011
3	Cardiotoxicity 03/2021 - 01/2014
2	Poisoning 12/2019 - 01/2016
1	Fatigue 03/2021
1	Obesity 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Dengue (Dengue Fever) 12/2018
1	Carcinoma (Carcinomatosis) 03/2015
1	Cardiac Arrhythmias (Arrythmia) 01/2014
1	Heart Arrest (Cardiac Arrest) 01/2014
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2014
1	Torsades de Pointes (Torsade de Pointes) 01/2014
1	Chronic Pain 01/2014
1	Drug-Related Side Effects and Adverse Reactions 03/2013
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2012
1	Type 2 Diabetes Mellitus (MODY) 06/2011
1	Hepatocellular Carcinoma (Hepatoma) 02/2011
1	Renal Cell Carcinoma (Grawitz Tumor) 07/2009

3	mitragynineIBA 12/2019 - 01/2014
2	14-deoxy-11,12-didehydroandrographolideIBA 06/2016 - 01/2016
2	GlucosidasesIBA 03/2015 - 06/2011
1	FlavonoidsIBA 03/2021
1	PolyphenolsIBA 03/2021
1	NitratesIBA 03/2021
1	Sirtuin 1IBA 01/2021
1	CarbohydratesIBA 01/2021
1	NAD (NADH)IBA 01/2021
1	Pharmaceutical PreparationsIBA 12/2018
1	Peptide Hydrolases (Proteases)FDA Link 12/2018
1	Potassium Channels (Potassium Channel)IBA 09/2017
1	DiterpenesIBA 01/2016
1	ApigeninIBA 03/2015
1	Tocopherols (Tocopherol)IBA 03/2015
1	Opioid Analgesics (Opioids)IBA 01/2014
1	PhytochemicalsIBA 01/2014
1	Sirolimus (Rapamycin)FDA Link 07/2013
1	EnzymesIBA 03/2013
1	Cyclin-Dependent Kinase Inhibitor p15IBA 01/2012
1	Free RadicalsIBA 06/2011
1	andrographolideIBA 02/2011
1	CytochromesIBA 02/2011
1	MTOR InhibitorsIBA 07/2009
1	temsirolimus FDA Link 07/2009
1	Proteins (Proteins, Gene)FDA Link 01/2009